averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
NFIL3
|
ENSG00000165030.3 | nuclear factor, interleukin 3 regulated |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NFIL3 | hg19_v2_chr9_-_94186131_94186174 | -0.18 | 6.5e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_-_27468842 | 48.76 |
ENST00000523500.1
|
CLU
|
clusterin |
chr5_+_150404904 | 27.97 |
ENST00000521632.1
|
GPX3
|
glutathione peroxidase 3 (plasma) |
chr4_-_88450612 | 27.68 |
ENST00000418378.1
ENST00000282470.6 |
SPARCL1
|
SPARC-like 1 (hevin) |
chr10_-_5046042 | 27.07 |
ENST00000421196.3
ENST00000455190.1 |
AKR1C2
|
aldo-keto reductase family 1, member C2 |
chr12_-_91573132 | 26.82 |
ENST00000550563.1
ENST00000546370.1 |
DCN
|
decorin |
chr11_-_5248294 | 26.64 |
ENST00000335295.4
|
HBB
|
hemoglobin, beta |
chr12_-_91573316 | 25.18 |
ENST00000393155.1
|
DCN
|
decorin |
chr12_-_91573249 | 23.96 |
ENST00000550099.1
ENST00000546391.1 ENST00000551354.1 |
DCN
|
decorin |
chr9_+_139871948 | 23.58 |
ENST00000224167.2
ENST00000457950.1 ENST00000371625.3 ENST00000371623.3 |
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
chr8_-_27468945 | 23.38 |
ENST00000405140.3
|
CLU
|
clusterin |
chr10_+_5005445 | 21.45 |
ENST00000380872.4
|
AKR1C1
|
aldo-keto reductase family 1, member C1 |
chr3_+_10068095 | 20.97 |
ENST00000287647.3
ENST00000383807.1 ENST00000383806.1 ENST00000419585.1 |
FANCD2
|
Fanconi anemia, complementation group D2 |
chr10_+_5005598 | 20.66 |
ENST00000442997.1
|
AKR1C1
|
aldo-keto reductase family 1, member C1 |
chr19_+_45409011 | 20.37 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
chr4_-_57524061 | 19.46 |
ENST00000508121.1
|
HOPX
|
HOP homeobox |
chr12_-_91574142 | 18.44 |
ENST00000547937.1
|
DCN
|
decorin |
chr4_-_88450244 | 18.43 |
ENST00000503414.1
|
SPARCL1
|
SPARC-like 1 (hevin) |
chr8_-_27469196 | 18.38 |
ENST00000546343.1
ENST00000560566.1 |
CLU
|
clusterin |
chr1_+_169079823 | 18.25 |
ENST00000367813.3
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr21_+_27011584 | 18.08 |
ENST00000400532.1
ENST00000480456.1 ENST00000312957.5 |
JAM2
|
junctional adhesion molecule 2 |
chr14_+_93389425 | 17.64 |
ENST00000216492.5
ENST00000334654.4 |
CHGA
|
chromogranin A (parathyroid secretory protein 1) |
chr6_-_116601044 | 17.39 |
ENST00000368608.3
|
TSPYL1
|
TSPY-like 1 |
chr1_-_230850043 | 17.10 |
ENST00000366667.4
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
chr6_-_116575226 | 16.68 |
ENST00000420283.1
|
TSPYL4
|
TSPY-like 4 |
chrX_-_102319092 | 16.52 |
ENST00000372728.3
|
BEX1
|
brain expressed, X-linked 1 |
chr5_-_131892501 | 16.14 |
ENST00000450655.1
|
IL5
|
interleukin 5 (colony-stimulating factor, eosinophil) |
chr14_-_21516590 | 15.76 |
ENST00000555026.1
|
NDRG2
|
NDRG family member 2 |
chr11_-_128894053 | 15.43 |
ENST00000392657.3
|
ARHGAP32
|
Rho GTPase activating protein 32 |
chr2_-_175712270 | 14.99 |
ENST00000295497.7
ENST00000444394.1 |
CHN1
|
chimerin 1 |
chrX_-_13835461 | 14.90 |
ENST00000316715.4
ENST00000356942.5 |
GPM6B
|
glycoprotein M6B |
chr12_+_10365404 | 14.72 |
ENST00000266458.5
ENST00000421801.2 ENST00000544284.1 ENST00000545047.1 ENST00000543602.1 ENST00000545887.1 |
GABARAPL1
|
GABA(A) receptor-associated protein like 1 |
chr12_-_91572278 | 14.66 |
ENST00000425043.1
ENST00000420120.2 ENST00000441303.2 ENST00000456569.2 |
DCN
|
decorin |
chr3_+_49027308 | 14.57 |
ENST00000383729.4
ENST00000343546.4 |
P4HTM
|
prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum) |
chr5_+_150400124 | 14.52 |
ENST00000388825.4
ENST00000521650.1 ENST00000517973.1 |
GPX3
|
glutathione peroxidase 3 (plasma) |
chr8_-_42397037 | 14.35 |
ENST00000342228.3
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2 |
chr17_+_56315936 | 13.97 |
ENST00000543544.1
|
LPO
|
lactoperoxidase |
chr11_+_62104897 | 13.80 |
ENST00000415229.2
ENST00000535727.1 ENST00000301776.5 |
ASRGL1
|
asparaginase like 1 |
chr11_-_5255696 | 13.31 |
ENST00000292901.3
ENST00000417377.1 |
HBD
|
hemoglobin, delta |
chr6_-_46459099 | 13.25 |
ENST00000371374.1
|
RCAN2
|
regulator of calcineurin 2 |
chr16_-_53537105 | 13.04 |
ENST00000568596.1
ENST00000570004.1 ENST00000564497.1 ENST00000300245.4 ENST00000394657.7 |
AKTIP
|
AKT interacting protein |
chr11_+_73358594 | 13.00 |
ENST00000227214.6
ENST00000398494.4 ENST00000543085.1 |
PLEKHB1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr4_+_69962185 | 12.93 |
ENST00000305231.7
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
chr3_+_111717511 | 12.37 |
ENST00000478951.1
ENST00000393917.2 |
TAGLN3
|
transgelin 3 |
chr6_+_150690028 | 12.26 |
ENST00000229447.5
ENST00000344419.3 |
IYD
|
iodotyrosine deiodinase |
chr10_-_97321112 | 12.24 |
ENST00000607232.1
ENST00000371227.4 ENST00000371249.2 ENST00000371247.2 ENST00000371246.2 ENST00000393949.1 ENST00000353505.5 ENST00000347291.4 |
SORBS1
|
sorbin and SH3 domain containing 1 |
chr11_-_64885111 | 12.04 |
ENST00000528598.1
ENST00000310597.4 |
ZNHIT2
|
zinc finger, HIT-type containing 2 |
chr10_-_69597810 | 11.86 |
ENST00000483798.2
|
DNAJC12
|
DnaJ (Hsp40) homolog, subfamily C, member 12 |
chr1_+_168148273 | 11.82 |
ENST00000367830.3
|
TIPRL
|
TIP41, TOR signaling pathway regulator-like (S. cerevisiae) |
chr5_+_36608422 | 11.76 |
ENST00000381918.3
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
chr2_+_79412357 | 11.62 |
ENST00000466387.1
|
CTNNA2
|
catenin (cadherin-associated protein), alpha 2 |
chrX_-_73072534 | 11.56 |
ENST00000429829.1
|
XIST
|
X inactive specific transcript (non-protein coding) |
chr3_-_45883558 | 11.48 |
ENST00000445698.1
ENST00000296135.6 |
LZTFL1
|
leucine zipper transcription factor-like 1 |
chr19_+_57791419 | 11.47 |
ENST00000537645.1
|
ZNF460
|
zinc finger protein 460 |
chr6_-_27782548 | 11.43 |
ENST00000333151.3
|
HIST1H2AJ
|
histone cluster 1, H2aj |
chr6_+_27833034 | 11.34 |
ENST00000357320.2
|
HIST1H2AL
|
histone cluster 1, H2al |
chr13_-_52378231 | 11.23 |
ENST00000280056.2
ENST00000444610.2 |
DHRS12
|
dehydrogenase/reductase (SDR family) member 12 |
chr6_+_121756809 | 11.14 |
ENST00000282561.3
|
GJA1
|
gap junction protein, alpha 1, 43kDa |
chr11_+_17373273 | 11.03 |
ENST00000338965.4
|
NCR3LG1
|
natural killer cell cytotoxicity receptor 3 ligand 1 |
chr14_-_22005343 | 10.95 |
ENST00000327430.3
|
SALL2
|
spalt-like transcription factor 2 |
chr8_-_120651020 | 10.85 |
ENST00000522826.1
ENST00000520066.1 ENST00000259486.6 ENST00000075322.6 |
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
chr11_-_85376121 | 10.80 |
ENST00000527447.1
|
CREBZF
|
CREB/ATF bZIP transcription factor |
chr6_+_131894284 | 10.78 |
ENST00000368087.3
ENST00000356962.2 |
ARG1
|
arginase 1 |
chr9_-_104249400 | 10.77 |
ENST00000374848.3
|
TMEM246
|
transmembrane protein 246 |
chr6_+_111580508 | 10.66 |
ENST00000368847.4
|
KIAA1919
|
KIAA1919 |
chr7_-_31380502 | 10.64 |
ENST00000297142.3
|
NEUROD6
|
neuronal differentiation 6 |
chr4_+_69962212 | 10.60 |
ENST00000508661.1
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
chr2_+_102927962 | 10.58 |
ENST00000233954.1
ENST00000393393.3 ENST00000410040.1 |
IL1RL1
IL18R1
|
interleukin 1 receptor-like 1 interleukin 18 receptor 1 |
chr3_+_148447887 | 10.55 |
ENST00000475347.1
ENST00000474935.1 ENST00000461609.1 |
AGTR1
|
angiotensin II receptor, type 1 |
chr5_+_140739537 | 10.43 |
ENST00000522605.1
|
PCDHGB2
|
protocadherin gamma subfamily B, 2 |
chr11_+_57365150 | 10.42 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
chr7_+_20686946 | 10.29 |
ENST00000443026.2
ENST00000406935.1 |
ABCB5
|
ATP-binding cassette, sub-family B (MDR/TAP), member 5 |
chr5_+_140165876 | 10.27 |
ENST00000504120.2
ENST00000394633.3 ENST00000378133.3 |
PCDHA1
|
protocadherin alpha 1 |
chr5_+_140227048 | 10.21 |
ENST00000532602.1
|
PCDHA9
|
protocadherin alpha 9 |
chr3_-_127455200 | 10.19 |
ENST00000398101.3
|
MGLL
|
monoglyceride lipase |
chr2_+_149632783 | 10.18 |
ENST00000435030.1
|
KIF5C
|
kinesin family member 5C |
chr9_+_37753795 | 10.13 |
ENST00000377753.2
ENST00000537911.1 ENST00000377754.2 ENST00000297994.3 |
TRMT10B
|
tRNA methyltransferase 10 homolog B (S. cerevisiae) |
chr20_+_42839600 | 10.09 |
ENST00000439943.1
ENST00000437730.1 |
OSER1-AS1
|
OSER1 antisense RNA 1 (head to head) |
chr6_-_31940065 | 10.09 |
ENST00000375349.3
ENST00000337523.5 |
DXO
|
decapping exoribonuclease |
chr17_-_41465674 | 10.06 |
ENST00000592135.1
ENST00000587874.1 ENST00000588654.1 ENST00000592094.1 |
LINC00910
|
long intergenic non-protein coding RNA 910 |
chr10_-_95360983 | 10.03 |
ENST00000371464.3
|
RBP4
|
retinol binding protein 4, plasma |
chr22_-_44258360 | 9.96 |
ENST00000330884.4
ENST00000249130.5 |
SULT4A1
|
sulfotransferase family 4A, member 1 |
chr11_-_5255861 | 9.89 |
ENST00000380299.3
|
HBD
|
hemoglobin, delta |
chr11_+_61891445 | 9.86 |
ENST00000394818.3
ENST00000533896.1 ENST00000278849.4 |
INCENP
|
inner centromere protein antigens 135/155kDa |
chr1_+_92632542 | 9.71 |
ENST00000409154.4
ENST00000370378.4 |
KIAA1107
|
KIAA1107 |
chr17_-_76836729 | 9.66 |
ENST00000587783.1
ENST00000542802.3 ENST00000586531.1 ENST00000589424.1 ENST00000590546.2 |
USP36
|
ubiquitin specific peptidase 36 |
chr13_-_45010939 | 9.60 |
ENST00000261489.2
|
TSC22D1
|
TSC22 domain family, member 1 |
chr19_+_16999654 | 9.55 |
ENST00000248076.3
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3 |
chr20_+_42839722 | 9.47 |
ENST00000442383.1
ENST00000435163.1 |
OSER1-AS1
|
OSER1 antisense RNA 1 (head to head) |
chr1_+_228353495 | 9.45 |
ENST00000366711.3
|
IBA57
|
IBA57, iron-sulfur cluster assembly homolog (S. cerevisiae) |
chr17_+_38083977 | 9.35 |
ENST00000578802.1
ENST00000578478.1 ENST00000582263.1 |
RP11-387H17.4
|
RP11-387H17.4 |
chr17_-_4167142 | 9.32 |
ENST00000570535.1
ENST00000574367.1 ENST00000341657.4 ENST00000433651.1 |
ANKFY1
|
ankyrin repeat and FYVE domain containing 1 |
chr4_-_73935409 | 9.05 |
ENST00000507544.2
ENST00000295890.4 |
COX18
|
COX18 cytochrome C oxidase assembly factor |
chr9_+_91933726 | 8.89 |
ENST00000534113.2
|
SECISBP2
|
SECIS binding protein 2 |
chrX_+_16737718 | 8.83 |
ENST00000380155.3
|
SYAP1
|
synapse associated protein 1 |
chr3_-_186288097 | 8.77 |
ENST00000446782.1
|
TBCCD1
|
TBCC domain containing 1 |
chr1_-_48937682 | 8.76 |
ENST00000371843.3
|
SPATA6
|
spermatogenesis associated 6 |
chr10_-_45474237 | 8.75 |
ENST00000448778.1
ENST00000298295.3 |
C10orf10
|
chromosome 10 open reading frame 10 |
chr4_+_185395947 | 8.71 |
ENST00000605834.1
|
RP11-326I11.3
|
RP11-326I11.3 |
chr19_+_45417921 | 8.70 |
ENST00000252491.4
ENST00000592885.1 ENST00000589781.1 |
APOC1
|
apolipoprotein C-I |
chr11_+_17281900 | 8.69 |
ENST00000530527.1
|
NUCB2
|
nucleobindin 2 |
chr6_-_11779840 | 8.64 |
ENST00000506810.1
|
ADTRP
|
androgen-dependent TFPI-regulating protein |
chr1_-_48937821 | 8.62 |
ENST00000396199.3
|
SPATA6
|
spermatogenesis associated 6 |
chr6_-_52668605 | 8.58 |
ENST00000334575.5
|
GSTA1
|
glutathione S-transferase alpha 1 |
chr1_-_48937838 | 8.43 |
ENST00000371847.3
|
SPATA6
|
spermatogenesis associated 6 |
chr20_+_44036900 | 8.42 |
ENST00000443296.1
|
DBNDD2
|
dysbindin (dystrobrevin binding protein 1) domain containing 2 |
chr19_+_57831829 | 8.39 |
ENST00000321545.4
|
ZNF543
|
zinc finger protein 543 |
chr9_-_99381660 | 8.22 |
ENST00000375240.3
ENST00000463569.1 |
CDC14B
|
cell division cycle 14B |
chr14_+_94577074 | 8.16 |
ENST00000444961.1
ENST00000448882.1 ENST00000557098.1 ENST00000554800.1 ENST00000556544.1 ENST00000298902.5 ENST00000555819.1 ENST00000557634.1 ENST00000555744.1 |
IFI27
|
interferon, alpha-inducible protein 27 |
chr10_-_90712520 | 8.15 |
ENST00000224784.6
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta |
chr1_-_15850676 | 8.15 |
ENST00000440484.1
ENST00000333868.5 |
CASP9
|
caspase 9, apoptosis-related cysteine peptidase |
chr15_+_91643442 | 8.14 |
ENST00000394232.1
|
SV2B
|
synaptic vesicle glycoprotein 2B |
chr10_-_97321165 | 8.14 |
ENST00000306402.6
|
SORBS1
|
sorbin and SH3 domain containing 1 |
chr1_+_20959943 | 8.12 |
ENST00000321556.4
|
PINK1
|
PTEN induced putative kinase 1 |
chr4_+_74275057 | 8.11 |
ENST00000511370.1
|
ALB
|
albumin |
chr17_-_73851285 | 8.10 |
ENST00000589642.1
ENST00000593002.1 ENST00000590221.1 ENST00000344296.4 ENST00000587374.1 ENST00000585462.1 ENST00000433525.2 ENST00000254806.3 |
WBP2
|
WW domain binding protein 2 |
chr20_+_49575342 | 7.98 |
ENST00000244051.1
|
MOCS3
|
molybdenum cofactor synthesis 3 |
chr2_-_201936302 | 7.94 |
ENST00000453765.1
ENST00000452799.1 ENST00000446678.1 ENST00000418596.3 |
FAM126B
|
family with sequence similarity 126, member B |
chr20_+_56136136 | 7.93 |
ENST00000319441.4
ENST00000543666.1 |
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble) |
chr15_+_68924327 | 7.93 |
ENST00000543950.1
|
CORO2B
|
coronin, actin binding protein, 2B |
chr17_-_36956155 | 7.79 |
ENST00000269554.3
|
PIP4K2B
|
phosphatidylinositol-5-phosphate 4-kinase, type II, beta |
chr1_+_152635854 | 7.78 |
ENST00000368784.1
|
LCE2D
|
late cornified envelope 2D |
chr7_+_44646177 | 7.73 |
ENST00000443864.2
ENST00000447398.1 ENST00000449767.1 ENST00000419661.1 |
OGDH
|
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
chr19_+_2841433 | 7.70 |
ENST00000334241.4
ENST00000585966.1 ENST00000591539.1 |
ZNF555
|
zinc finger protein 555 |
chr19_-_460996 | 7.65 |
ENST00000264554.6
|
SHC2
|
SHC (Src homology 2 domain containing) transforming protein 2 |
chrX_+_102469997 | 7.55 |
ENST00000372695.5
ENST00000372691.3 |
BEX4
|
brain expressed, X-linked 4 |
chr8_+_21916710 | 7.54 |
ENST00000523266.1
ENST00000519907.1 |
DMTN
|
dematin actin binding protein |
chr13_-_52378281 | 7.52 |
ENST00000218981.1
|
DHRS12
|
dehydrogenase/reductase (SDR family) member 12 |
chr10_-_52645416 | 7.50 |
ENST00000374001.2
ENST00000373997.3 ENST00000373995.3 ENST00000282641.2 ENST00000395495.1 ENST00000414883.1 |
A1CF
|
APOBEC1 complementation factor |
chr1_-_86043921 | 7.49 |
ENST00000535924.2
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1 |
chr8_-_110703819 | 7.49 |
ENST00000532779.1
ENST00000534578.1 |
SYBU
|
syntabulin (syntaxin-interacting) |
chr3_+_149191723 | 7.47 |
ENST00000305354.4
|
TM4SF4
|
transmembrane 4 L six family member 4 |
chr19_+_45418067 | 7.46 |
ENST00000589078.1
ENST00000586638.1 |
APOC1
|
apolipoprotein C-I |
chr10_-_69597915 | 7.46 |
ENST00000225171.2
|
DNAJC12
|
DnaJ (Hsp40) homolog, subfamily C, member 12 |
chr8_+_21916680 | 7.41 |
ENST00000358242.3
ENST00000415253.1 |
DMTN
|
dematin actin binding protein |
chr9_-_95298314 | 7.38 |
ENST00000344604.5
ENST00000375540.1 |
ECM2
|
extracellular matrix protein 2, female organ and adipocyte specific |
chr5_+_156696362 | 7.36 |
ENST00000377576.3
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
chr1_-_16345245 | 7.33 |
ENST00000311890.9
|
HSPB7
|
heat shock 27kDa protein family, member 7 (cardiovascular) |
chr4_+_159593418 | 7.27 |
ENST00000507475.1
ENST00000307738.5 |
ETFDH
|
electron-transferring-flavoprotein dehydrogenase |
chr12_+_124997766 | 7.26 |
ENST00000543970.1
|
RP11-83B20.1
|
RP11-83B20.1 |
chr16_+_3507985 | 7.25 |
ENST00000421765.3
ENST00000360862.5 ENST00000414063.2 ENST00000610180.1 ENST00000608993.1 |
NAA60
NAA60
|
N(alpha)-acetyltransferase 60, NatF catalytic subunit N-alpha-acetyltransferase 60 |
chr11_-_123525289 | 7.25 |
ENST00000392770.2
ENST00000299333.3 ENST00000530277.1 |
SCN3B
|
sodium channel, voltage-gated, type III, beta subunit |
chr1_+_15671919 | 7.24 |
ENST00000314668.9
|
FHAD1
|
forkhead-associated (FHA) phosphopeptide binding domain 1 |
chr16_+_7382745 | 7.18 |
ENST00000436368.2
ENST00000311745.5 ENST00000355637.4 ENST00000340209.4 |
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
chr11_-_14993819 | 7.15 |
ENST00000396372.2
ENST00000361010.3 ENST00000359642.3 ENST00000331587.4 |
CALCA
|
calcitonin-related polypeptide alpha |
chrX_-_140271249 | 7.13 |
ENST00000370526.2
|
LDOC1
|
leucine zipper, down-regulated in cancer 1 |
chr9_-_104198042 | 7.11 |
ENST00000374855.4
|
ALDOB
|
aldolase B, fructose-bisphosphate |
chr10_-_27444143 | 7.06 |
ENST00000477432.1
|
YME1L1
|
YME1-like 1 ATPase |
chr10_-_61720640 | 7.04 |
ENST00000521074.1
ENST00000444900.1 |
C10orf40
|
chromosome 10 open reading frame 40 |
chr1_+_163039143 | 7.03 |
ENST00000531057.1
ENST00000527809.1 ENST00000367908.4 |
RGS4
|
regulator of G-protein signaling 4 |
chr20_-_43729750 | 7.03 |
ENST00000537075.1
ENST00000306117.1 |
KCNS1
|
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 |
chr5_-_139943830 | 7.02 |
ENST00000412920.3
ENST00000511201.2 ENST00000356738.2 ENST00000354402.5 ENST00000358580.5 ENST00000508496.2 |
APBB3
|
amyloid beta (A4) precursor protein-binding, family B, member 3 |
chr5_-_133706695 | 7.01 |
ENST00000521755.1
ENST00000523054.1 ENST00000435240.2 ENST00000609654.1 ENST00000536186.1 ENST00000609383.1 |
CDKL3
|
cyclin-dependent kinase-like 3 |
chr17_-_34329084 | 6.99 |
ENST00000354059.4
ENST00000536149.1 |
CCL15
CCL14
|
chemokine (C-C motif) ligand 15 chemokine (C-C motif) ligand 14 |
chr10_-_7661623 | 6.96 |
ENST00000298441.6
|
ITIH5
|
inter-alpha-trypsin inhibitor heavy chain family, member 5 |
chr12_-_71182695 | 6.88 |
ENST00000342084.4
|
PTPRR
|
protein tyrosine phosphatase, receptor type, R |
chr11_+_124492749 | 6.87 |
ENST00000531667.1
ENST00000441174.3 ENST00000375005.4 |
TBRG1
|
transforming growth factor beta regulator 1 |
chr3_+_186383741 | 6.83 |
ENST00000232003.4
|
HRG
|
histidine-rich glycoprotein |
chr12_-_123215306 | 6.81 |
ENST00000356987.2
ENST00000436083.2 |
HCAR1
|
hydroxycarboxylic acid receptor 1 |
chr1_-_149832704 | 6.81 |
ENST00000392933.1
ENST00000369157.2 ENST00000392932.4 |
HIST2H4B
|
histone cluster 2, H4b |
chr17_+_56315787 | 6.78 |
ENST00000262290.4
ENST00000421678.2 |
LPO
|
lactoperoxidase |
chr1_+_149804218 | 6.76 |
ENST00000610125.1
|
HIST2H4A
|
histone cluster 2, H4a |
chr7_-_15601595 | 6.72 |
ENST00000342526.3
|
AGMO
|
alkylglycerol monooxygenase |
chr5_+_140734570 | 6.70 |
ENST00000571252.1
|
PCDHGA4
|
protocadherin gamma subfamily A, 4 |
chr6_+_27782788 | 6.64 |
ENST00000359465.4
|
HIST1H2BM
|
histone cluster 1, H2bm |
chr5_-_140013275 | 6.55 |
ENST00000512545.1
ENST00000302014.6 ENST00000401743.2 |
CD14
|
CD14 molecule |
chr19_+_10217270 | 6.52 |
ENST00000446223.1
|
PPAN
|
peter pan homolog (Drosophila) |
chr15_+_42841008 | 6.51 |
ENST00000260372.3
ENST00000568876.1 ENST00000568846.2 ENST00000562398.1 |
HAUS2
|
HAUS augmin-like complex, subunit 2 |
chr2_-_216300784 | 6.48 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
chr12_+_7014064 | 6.45 |
ENST00000443597.2
|
LRRC23
|
leucine rich repeat containing 23 |
chr1_-_230513367 | 6.44 |
ENST00000321327.2
ENST00000525115.1 |
PGBD5
|
piggyBac transposable element derived 5 |
chrX_+_110339439 | 6.43 |
ENST00000372010.1
ENST00000519681.1 ENST00000372007.5 |
PAK3
|
p21 protein (Cdc42/Rac)-activated kinase 3 |
chr9_-_99064429 | 6.42 |
ENST00000375263.3
|
HSD17B3
|
hydroxysteroid (17-beta) dehydrogenase 3 |
chr4_+_69681710 | 6.42 |
ENST00000265403.7
ENST00000458688.2 |
UGT2B10
|
UDP glucuronosyltransferase 2 family, polypeptide B10 |
chr2_+_234602305 | 6.42 |
ENST00000406651.1
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6 |
chr12_-_50297638 | 6.39 |
ENST00000320634.3
|
FAIM2
|
Fas apoptotic inhibitory molecule 2 |
chr15_-_78913521 | 6.39 |
ENST00000326828.5
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal) |
chr4_-_153303658 | 6.30 |
ENST00000296555.5
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
chr18_-_5396271 | 6.28 |
ENST00000579951.1
|
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3 |
chr4_+_668348 | 6.28 |
ENST00000511290.1
|
MYL5
|
myosin, light chain 5, regulatory |
chr5_-_146435694 | 6.26 |
ENST00000356826.3
|
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta |
chr22_-_32334403 | 6.25 |
ENST00000543051.1
|
C22orf24
|
chromosome 22 open reading frame 24 |
chr10_-_124639062 | 6.22 |
ENST00000368898.3
ENST00000368896.1 ENST00000545804.1 |
FAM24B
CUZD1
|
family with sequence similarity 24, member B CUB and zona pellucida-like domains 1 |
chr15_-_80634104 | 6.21 |
ENST00000561432.1
ENST00000558913.1 ENST00000558578.1 |
LINC00927
|
long intergenic non-protein coding RNA 927 |
chr12_-_6772303 | 6.20 |
ENST00000396807.4
ENST00000446105.2 ENST00000341550.4 |
ING4
|
inhibitor of growth family, member 4 |
chr1_+_196788887 | 6.17 |
ENST00000320493.5
ENST00000367424.4 ENST00000367421.3 |
CFHR1
CFHR2
|
complement factor H-related 1 complement factor H-related 2 |
chr11_-_72145426 | 6.17 |
ENST00000535990.1
ENST00000437826.2 ENST00000340729.5 |
CLPB
|
ClpB caseinolytic peptidase B homolog (E. coli) |
chr14_-_70263979 | 6.16 |
ENST00000216540.4
|
SLC10A1
|
solute carrier family 10 (sodium/bile acid cotransporter), member 1 |
chr19_-_38806560 | 6.13 |
ENST00000591755.1
ENST00000337679.8 ENST00000339413.6 |
YIF1B
|
Yip1 interacting factor homolog B (S. cerevisiae) |
chr11_-_117698765 | 6.12 |
ENST00000532119.1
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
chr12_+_7013897 | 6.11 |
ENST00000007969.8
ENST00000323702.5 |
LRRC23
|
leucine rich repeat containing 23 |
chr1_+_156698708 | 6.09 |
ENST00000519086.1
|
RRNAD1
|
ribosomal RNA adenine dimethylase domain containing 1 |
chr10_+_86004802 | 6.08 |
ENST00000359452.4
ENST00000358110.5 ENST00000372092.3 |
RGR
|
retinal G protein coupled receptor |
chr5_+_140762268 | 6.07 |
ENST00000518325.1
|
PCDHGA7
|
protocadherin gamma subfamily A, 7 |
chr11_+_62495541 | 6.06 |
ENST00000530625.1
ENST00000513247.2 |
TTC9C
|
tetratricopeptide repeat domain 9C |
chr13_-_33112899 | 6.03 |
ENST00000267068.3
ENST00000357505.6 ENST00000399396.3 |
N4BP2L2
|
NEDD4 binding protein 2-like 2 |
chr15_-_30113676 | 6.02 |
ENST00000400011.2
|
TJP1
|
tight junction protein 1 |
chr3_+_155860751 | 6.02 |
ENST00000471742.1
|
KCNAB1
|
potassium voltage-gated channel, shaker-related subfamily, beta member 1 |
chr19_+_36249057 | 6.02 |
ENST00000301165.5
ENST00000536950.1 ENST00000537459.1 ENST00000421853.2 |
C19orf55
|
chromosome 19 open reading frame 55 |
chr13_+_111855414 | 6.01 |
ENST00000375737.5
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7 |
chr3_+_186435137 | 6.01 |
ENST00000447445.1
|
KNG1
|
kininogen 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.1 | 90.5 | GO:1902998 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
14.2 | 42.5 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
9.9 | 69.4 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
9.7 | 116.9 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
8.0 | 8.0 | GO:0018307 | enzyme active site formation(GO:0018307) |
6.8 | 20.4 | GO:1902994 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
6.7 | 26.6 | GO:0030185 | nitric oxide transport(GO:0030185) |
5.9 | 17.6 | GO:2000705 | dense core granule biogenesis(GO:0061110) positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of dense core granule biogenesis(GO:2000705) |
5.7 | 17.1 | GO:0034226 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
5.4 | 16.1 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
4.6 | 18.2 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) positive regulation of potassium ion import(GO:1903288) |
4.0 | 16.2 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
3.8 | 11.4 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
3.6 | 10.8 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
3.5 | 21.0 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
3.4 | 13.5 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
3.2 | 12.7 | GO:1904640 | response to methionine(GO:1904640) |
3.1 | 3.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
3.0 | 8.9 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
2.9 | 8.8 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
2.8 | 11.1 | GO:0010652 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
2.7 | 8.2 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
2.7 | 8.1 | GO:1903384 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of cellular respiration(GO:1901857) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
2.6 | 10.3 | GO:0048749 | compound eye development(GO:0048749) |
2.5 | 5.0 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
2.5 | 14.9 | GO:0070560 | protein secretion by platelet(GO:0070560) |
2.4 | 7.1 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
2.4 | 7.1 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
2.3 | 11.7 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
2.3 | 9.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
2.3 | 11.5 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
2.2 | 13.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
2.1 | 14.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
2.1 | 6.2 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
2.0 | 6.1 | GO:0090427 | activation of meiosis(GO:0090427) |
2.0 | 6.0 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
1.8 | 7.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
1.8 | 7.2 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
1.8 | 8.9 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
1.8 | 1.8 | GO:1902081 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
1.8 | 8.8 | GO:0080009 | mRNA methylation(GO:0080009) |
1.7 | 10.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
1.7 | 13.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
1.7 | 8.5 | GO:0009804 | coumarin metabolic process(GO:0009804) |
1.7 | 23.2 | GO:0015671 | oxygen transport(GO:0015671) |
1.6 | 6.6 | GO:0071725 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
1.6 | 4.9 | GO:0001207 | histone displacement(GO:0001207) regulation of transcription involved in meiotic cell cycle(GO:0051037) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
1.6 | 14.4 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.6 | 1.6 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
1.6 | 36.4 | GO:0052695 | cellular glucuronidation(GO:0052695) |
1.6 | 4.7 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
1.6 | 7.9 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
1.6 | 9.3 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
1.6 | 6.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.5 | 9.3 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
1.5 | 4.5 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) |
1.5 | 6.0 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
1.5 | 14.9 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.5 | 2.9 | GO:0052314 | isoquinoline alkaloid metabolic process(GO:0033076) phytoalexin metabolic process(GO:0052314) |
1.5 | 10.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
1.5 | 4.4 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
1.4 | 11.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.4 | 4.2 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
1.4 | 7.0 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
1.4 | 4.2 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
1.4 | 8.2 | GO:0090131 | mesenchyme migration(GO:0090131) |
1.4 | 4.1 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
1.3 | 16.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
1.3 | 22.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.3 | 9.1 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
1.3 | 7.8 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
1.3 | 13.8 | GO:0032025 | response to cobalt ion(GO:0032025) |
1.3 | 5.0 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
1.2 | 16.9 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
1.2 | 18.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.2 | 9.6 | GO:0060155 | platelet dense granule organization(GO:0060155) |
1.2 | 3.6 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
1.2 | 7.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.2 | 3.5 | GO:1904479 | cellular response to bile acid(GO:1903413) negative regulation of intestinal absorption(GO:1904479) response to iron ion starvation(GO:1990641) |
1.2 | 5.8 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
1.2 | 8.1 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
1.1 | 5.7 | GO:0006875 | cellular metal ion homeostasis(GO:0006875) |
1.1 | 4.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.1 | 5.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.1 | 4.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.1 | 3.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.1 | 3.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.1 | 5.3 | GO:0035617 | stress granule disassembly(GO:0035617) |
1.1 | 3.2 | GO:0034255 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
1.1 | 2.1 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
1.0 | 3.1 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
1.0 | 15.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
1.0 | 11.2 | GO:0003351 | epithelial cilium movement(GO:0003351) |
1.0 | 3.0 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
1.0 | 3.0 | GO:2000724 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
1.0 | 10.8 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.0 | 3.0 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.0 | 5.9 | GO:0016075 | rRNA catabolic process(GO:0016075) |
1.0 | 22.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.0 | 3.9 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
1.0 | 6.7 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.0 | 16.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
1.0 | 12.4 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.9 | 15.1 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.9 | 3.7 | GO:1902159 | regulation of inward rectifier potassium channel activity(GO:1901979) regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) |
0.9 | 25.9 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.9 | 7.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.9 | 8.2 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.9 | 9.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.9 | 20.7 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.9 | 6.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.9 | 9.9 | GO:0016925 | protein sumoylation(GO:0016925) |
0.9 | 11.6 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.9 | 23.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.9 | 2.7 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.9 | 4.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.9 | 12.1 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.8 | 5.1 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.8 | 5.0 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.8 | 7.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.8 | 2.5 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.8 | 3.2 | GO:0010193 | response to ozone(GO:0010193) |
0.8 | 4.8 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.8 | 4.8 | GO:0018343 | protein farnesylation(GO:0018343) |
0.8 | 5.5 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.8 | 2.4 | GO:0019477 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.8 | 3.9 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
0.8 | 2.3 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.8 | 3.9 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.8 | 3.9 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
0.8 | 13.9 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.8 | 4.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.8 | 3.8 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.7 | 3.0 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.7 | 3.0 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.7 | 3.7 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.7 | 3.7 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.7 | 4.4 | GO:0051012 | microtubule sliding(GO:0051012) |
0.7 | 0.7 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.7 | 24.3 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.7 | 7.1 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.7 | 3.6 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.7 | 22.7 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.7 | 10.6 | GO:0014029 | neural crest formation(GO:0014029) |
0.7 | 2.1 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.7 | 2.8 | GO:0019086 | late viral transcription(GO:0019086) |
0.7 | 19.5 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.7 | 4.0 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.7 | 2.0 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
0.7 | 6.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.7 | 3.3 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.7 | 3.9 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.7 | 7.8 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.7 | 3.9 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.6 | 15.5 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.6 | 16.7 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.6 | 1.9 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.6 | 3.1 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.6 | 4.3 | GO:0035799 | ureter maturation(GO:0035799) |
0.6 | 2.4 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.6 | 3.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.6 | 4.1 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.6 | 5.8 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.6 | 5.6 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.6 | 1.1 | GO:2000364 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
0.5 | 1.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.5 | 3.3 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.5 | 5.9 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.5 | 2.7 | GO:0006311 | meiotic gene conversion(GO:0006311) male meiosis chromosome segregation(GO:0007060) |
0.5 | 1.1 | GO:2000330 | positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.5 | 7.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.5 | 1.0 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.5 | 9.8 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.5 | 7.7 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.5 | 0.5 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.5 | 4.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.5 | 14.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.5 | 3.4 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.5 | 4.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.5 | 4.9 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.5 | 6.7 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.5 | 2.9 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.5 | 4.2 | GO:0015705 | iodide transport(GO:0015705) |
0.5 | 3.2 | GO:0042048 | olfactory behavior(GO:0042048) |
0.5 | 2.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.5 | 4.6 | GO:0016322 | neuron remodeling(GO:0016322) |
0.5 | 1.4 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
0.5 | 7.8 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.5 | 16.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.5 | 3.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.5 | 3.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.5 | 13.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.5 | 5.5 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.4 | 6.3 | GO:0042737 | drug catabolic process(GO:0042737) |
0.4 | 2.7 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.4 | 2.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.4 | 3.5 | GO:0070166 | enamel mineralization(GO:0070166) |
0.4 | 6.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.4 | 1.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.4 | 1.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.4 | 3.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.4 | 3.8 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 1.3 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
0.4 | 3.3 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.4 | 13.3 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.4 | 5.8 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.4 | 1.2 | GO:1903487 | regulation of lactation(GO:1903487) |
0.4 | 4.1 | GO:0000050 | urea cycle(GO:0000050) |
0.4 | 14.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.4 | 1.2 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.4 | 5.6 | GO:0017144 | drug metabolic process(GO:0017144) |
0.4 | 2.8 | GO:0001842 | neural fold formation(GO:0001842) |
0.4 | 4.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.4 | 2.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.4 | 1.9 | GO:0070092 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.4 | 1.9 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.4 | 2.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.4 | 3.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.4 | 10.6 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.4 | 2.2 | GO:0021915 | neural tube development(GO:0021915) |
0.4 | 8.4 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.4 | 4.4 | GO:0015871 | choline transport(GO:0015871) |
0.4 | 14.1 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
0.4 | 2.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.4 | 1.4 | GO:1903935 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
0.4 | 2.5 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.3 | 3.8 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 2.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 2.4 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.3 | 2.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 6.2 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.3 | 1.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.3 | 1.0 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.3 | 3.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 1.0 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 6.7 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.3 | 2.9 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
0.3 | 1.3 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.3 | 0.7 | GO:0070428 | nitric oxide production involved in inflammatory response(GO:0002537) negative regulation of interleukin-23 production(GO:0032707) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.3 | 3.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.3 | 9.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.3 | 2.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 3.5 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.3 | 2.8 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.3 | 0.6 | GO:1902573 | positive regulation of serine-type endopeptidase activity(GO:1900005) positive regulation of serine-type peptidase activity(GO:1902573) |
0.3 | 4.6 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.3 | 3.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 0.9 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.3 | 3.5 | GO:0006108 | oxaloacetate metabolic process(GO:0006107) malate metabolic process(GO:0006108) |
0.3 | 2.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.3 | 46.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 1.8 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.3 | 0.9 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.3 | 5.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.3 | 1.7 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.3 | 2.5 | GO:0031167 | rRNA methylation(GO:0031167) |
0.3 | 5.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 3.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.3 | 13.0 | GO:0007602 | phototransduction(GO:0007602) |
0.3 | 1.6 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.3 | 0.8 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.3 | 1.3 | GO:0022605 | ovarian cumulus expansion(GO:0001550) oogenesis stage(GO:0022605) fused antrum stage(GO:0048165) |
0.3 | 1.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) nonribosomal peptide biosynthetic process(GO:0019184) |
0.3 | 2.5 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.2 | 2.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 1.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 1.2 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.2 | 2.2 | GO:0034311 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
0.2 | 3.1 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
0.2 | 11.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.2 | 6.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 6.2 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 0.7 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 2.3 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 2.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 4.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 4.5 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.2 | 1.8 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.2 | 10.1 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.2 | 3.2 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.2 | 1.7 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.2 | 3.6 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.2 | 2.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 5.7 | GO:0006400 | tRNA modification(GO:0006400) |
0.2 | 3.1 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.2 | 2.9 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.2 | 1.6 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.2 | 2.9 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.2 | 3.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 6.5 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.2 | 0.6 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.2 | 2.2 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.2 | 6.0 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.2 | 2.8 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 2.4 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.2 | 1.0 | GO:0048754 | branching morphogenesis of an epithelial tube(GO:0048754) |
0.2 | 1.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 1.2 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.2 | 5.0 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.2 | 6.3 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 5.2 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.2 | 3.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 5.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.2 | 3.4 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.2 | 1.7 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.2 | 6.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.2 | 14.9 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.2 | 1.9 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 7.2 | GO:0001881 | receptor recycling(GO:0001881) |
0.2 | 7.0 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.2 | 2.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 14.4 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.2 | 1.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 8.3 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.2 | 0.8 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
0.1 | 3.5 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 1.0 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 2.3 | GO:0051194 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.1 | 4.6 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 2.5 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 1.9 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 6.5 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.1 | 0.7 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 2.4 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 5.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.5 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.1 | 6.1 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 1.7 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.1 | 1.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 2.6 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
0.1 | 3.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 3.3 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.1 | 3.0 | GO:0048854 | brain morphogenesis(GO:0048854) |
0.1 | 0.6 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.1 | 0.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.7 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
0.1 | 1.2 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 5.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.3 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.1 | 0.4 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 12.1 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 3.8 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 5.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 4.0 | GO:0098930 | axonal transport(GO:0098930) |
0.1 | 1.9 | GO:0032094 | response to food(GO:0032094) |
0.1 | 9.8 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.1 | 5.4 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 3.2 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) |
0.1 | 2.7 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 1.1 | GO:0007350 | blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 3.3 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 2.7 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 2.1 | GO:0001947 | heart looping(GO:0001947) |
0.1 | 1.8 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.2 | GO:0051493 | regulation of cytoskeleton organization(GO:0051493) |
0.1 | 0.4 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 7.1 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 1.7 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 1.5 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 6.3 | GO:0006937 | regulation of muscle contraction(GO:0006937) |
0.1 | 1.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 2.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 2.0 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.5 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.1 | 0.8 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.2 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 1.0 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.8 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 1.5 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 1.0 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.7 | GO:0003094 | glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
0.1 | 2.6 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 4.8 | GO:0007586 | digestion(GO:0007586) |
0.1 | 4.7 | GO:0008016 | regulation of heart contraction(GO:0008016) |
0.1 | 0.6 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.8 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 1.2 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.1 | 5.2 | GO:0008366 | ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) |
0.1 | 8.1 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.1 | 2.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 1.3 | GO:0034599 | cellular response to oxidative stress(GO:0034599) |
0.0 | 2.1 | GO:0050905 | neuromuscular process(GO:0050905) |
0.0 | 29.2 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 2.3 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.0 | 3.7 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.9 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.0 | 0.5 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.5 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.7 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.4 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 1.1 | GO:0043068 | positive regulation of apoptotic process(GO:0043065) positive regulation of programmed cell death(GO:0043068) |
0.0 | 0.8 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 1.4 | GO:0031214 | biomineral tissue development(GO:0031214) |
0.0 | 0.5 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 1.6 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.5 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.0 | 0.4 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.1 | GO:0099515 | vesicle transport along actin filament(GO:0030050) actin filament-based transport(GO:0099515) |
0.0 | 0.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.8 | 31.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
7.8 | 109.1 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
7.6 | 30.2 | GO:0097224 | sperm connecting piece(GO:0097224) |
6.8 | 20.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
6.5 | 90.5 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
4.4 | 13.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
4.1 | 20.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
3.7 | 11.0 | GO:0044423 | virion(GO:0019012) virion part(GO:0044423) |
3.5 | 13.8 | GO:0043293 | apoptosome(GO:0043293) |
3.3 | 13.0 | GO:0070695 | FHF complex(GO:0070695) |
3.2 | 3.2 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
2.5 | 12.5 | GO:0000801 | central element(GO:0000801) |
2.1 | 25.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
2.0 | 8.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.9 | 9.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.6 | 17.6 | GO:0042583 | chromaffin granule(GO:0042583) |
1.6 | 20.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.5 | 30.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
1.4 | 7.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.3 | 3.9 | GO:0098536 | deuterosome(GO:0098536) |
1.2 | 12.0 | GO:0097449 | astrocyte projection(GO:0097449) |
1.2 | 4.8 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
1.2 | 18.8 | GO:0042627 | chylomicron(GO:0042627) |
1.2 | 3.5 | GO:0033011 | perinuclear theca(GO:0033011) cytoskeletal calyx(GO:0033150) |
1.1 | 10.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.1 | 5.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
1.1 | 5.4 | GO:0005602 | complement component C1 complex(GO:0005602) |
1.0 | 7.0 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
1.0 | 4.9 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
1.0 | 3.9 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
1.0 | 2.9 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
1.0 | 26.8 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.9 | 19.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.9 | 6.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.9 | 12.8 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.8 | 5.0 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.8 | 5.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.8 | 14.4 | GO:0005922 | connexon complex(GO:0005922) |
0.8 | 13.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.7 | 3.7 | GO:0032021 | NELF complex(GO:0032021) |
0.7 | 2.9 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.7 | 2.6 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.6 | 4.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.6 | 3.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.6 | 1.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.6 | 4.1 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.6 | 2.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.6 | 7.5 | GO:0097433 | dense body(GO:0097433) |
0.6 | 23.5 | GO:0032590 | dendrite membrane(GO:0032590) |
0.5 | 4.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.5 | 7.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.5 | 8.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.5 | 6.0 | GO:0005921 | gap junction(GO:0005921) |
0.5 | 2.0 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.5 | 1.9 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.5 | 6.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.5 | 11.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.5 | 3.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 10.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.4 | 3.5 | GO:0045179 | apical cortex(GO:0045179) |
0.4 | 45.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.4 | 5.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 23.9 | GO:0000786 | nucleosome(GO:0000786) |
0.4 | 4.1 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.4 | 2.0 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.4 | 5.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 2.3 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.4 | 4.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 6.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.4 | 10.9 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.4 | 5.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.4 | 3.2 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 1.8 | GO:0031905 | early endosome lumen(GO:0031905) |
0.4 | 1.8 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.4 | 1.4 | GO:0031673 | H zone(GO:0031673) |
0.4 | 2.1 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.3 | 1.0 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.3 | 2.1 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 5.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 6.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 1.3 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.3 | 8.8 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 2.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 3.9 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 34.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.3 | 3.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.3 | 13.9 | GO:0097546 | ciliary base(GO:0097546) |
0.3 | 2.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 0.6 | GO:0097679 | other organism cytoplasm(GO:0097679) |
0.3 | 3.9 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.3 | 4.4 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 2.0 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 4.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.3 | 2.5 | GO:0016013 | syntrophin complex(GO:0016013) |
0.3 | 1.9 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.3 | 2.8 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.3 | 13.7 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 12.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 2.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 2.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 14.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.2 | 2.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 2.0 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 1.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 16.6 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 18.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.2 | 14.3 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 80.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.2 | 2.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 1.4 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 0.6 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.2 | 10.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 6.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 0.9 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.2 | 29.4 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 10.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 6.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 34.8 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.2 | 0.8 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 2.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 4.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 12.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 14.6 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 0.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 8.9 | GO:0035580 | specific granule lumen(GO:0035580) |
0.1 | 4.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 12.3 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 2.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 1.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.5 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.1 | 1.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 1.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 6.4 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 1.7 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 11.7 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.1 | 0.5 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.1 | 2.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 2.9 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 2.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 1.1 | GO:0031906 | late endosome lumen(GO:0031906) |
0.1 | 6.8 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 1.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 3.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 2.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 2.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 2.6 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.9 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 2.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 14.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 4.1 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 1.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 2.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 1.0 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 181.6 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0036513 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 1.0 | GO:0098791 | Golgi subcompartment(GO:0098791) |
0.0 | 8.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.3 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.0 | 1.9 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 6.4 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 1.5 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.7 | GO:0045171 | intercellular bridge(GO:0045171) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.5 | 69.2 | GO:0047115 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
6.8 | 20.4 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
6.2 | 18.6 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
5.9 | 23.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
5.6 | 33.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
5.4 | 16.1 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
5.0 | 15.1 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
4.5 | 90.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
4.5 | 13.5 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
3.9 | 42.5 | GO:0008430 | selenium binding(GO:0008430) |
3.1 | 9.3 | GO:0002113 | interleukin-33 binding(GO:0002113) |
3.1 | 18.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
2.9 | 8.8 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
2.7 | 10.8 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
2.7 | 16.0 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
2.6 | 7.9 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
2.6 | 7.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.5 | 30.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
2.5 | 7.4 | GO:0070052 | collagen V binding(GO:0070052) |
2.3 | 16.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
2.2 | 162.0 | GO:0050840 | extracellular matrix binding(GO:0050840) |
2.2 | 8.9 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
2.2 | 13.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.2 | 6.6 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
2.2 | 8.7 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
2.1 | 23.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.9 | 11.1 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
1.8 | 5.5 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
1.8 | 7.4 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
1.8 | 29.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
1.8 | 10.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.8 | 7.1 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
1.8 | 8.9 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
1.7 | 5.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.7 | 23.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.7 | 5.1 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
1.7 | 11.8 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
1.6 | 12.9 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
1.6 | 6.5 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
1.6 | 9.5 | GO:0048039 | ubiquinone binding(GO:0048039) |
1.5 | 6.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.5 | 4.6 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.5 | 8.9 | GO:0004882 | androgen receptor activity(GO:0004882) |
1.4 | 7.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.4 | 1.4 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
1.4 | 4.2 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
1.4 | 4.2 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
1.4 | 4.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
1.4 | 8.2 | GO:1903135 | cupric ion binding(GO:1903135) |
1.3 | 8.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.3 | 15.7 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
1.3 | 49.4 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
1.3 | 5.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.3 | 5.0 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
1.2 | 3.7 | GO:0004488 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
1.2 | 4.8 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
1.2 | 6.0 | GO:0038064 | protein tyrosine kinase collagen receptor activity(GO:0038062) collagen receptor activity(GO:0038064) |
1.2 | 4.7 | GO:0019862 | IgA binding(GO:0019862) |
1.2 | 7.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.1 | 3.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.1 | 4.5 | GO:0061714 | folic acid receptor activity(GO:0061714) |
1.1 | 4.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.1 | 18.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
1.1 | 9.6 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
1.1 | 3.2 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
1.1 | 14.7 | GO:0030957 | Tat protein binding(GO:0030957) |
1.0 | 3.1 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) |
1.0 | 3.0 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
1.0 | 3.0 | GO:0016992 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
1.0 | 3.0 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
1.0 | 3.9 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
1.0 | 2.9 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
1.0 | 14.3 | GO:0016918 | retinal binding(GO:0016918) |
0.9 | 17.6 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.9 | 4.5 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.9 | 5.3 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.9 | 7.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.9 | 5.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.9 | 7.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.8 | 7.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.8 | 5.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.8 | 2.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.8 | 8.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.8 | 21.0 | GO:0005521 | lamin binding(GO:0005521) |
0.8 | 2.4 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.8 | 10.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.8 | 10.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.8 | 2.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.8 | 5.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.8 | 6.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.8 | 3.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.8 | 11.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.7 | 3.7 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.7 | 2.9 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.7 | 4.4 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.7 | 3.5 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.7 | 16.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.7 | 4.0 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.7 | 2.7 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.6 | 7.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.6 | 4.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.6 | 5.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.6 | 1.9 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.6 | 6.9 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.6 | 1.9 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.6 | 3.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.6 | 1.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.6 | 16.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.6 | 13.7 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.6 | 1.8 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.6 | 6.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.6 | 7.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.6 | 1.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.6 | 9.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.5 | 1.6 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.5 | 2.7 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.5 | 1.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.5 | 2.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.5 | 1.6 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.5 | 1.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.5 | 10.0 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.5 | 2.5 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.5 | 14.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.5 | 11.4 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.5 | 13.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.5 | 3.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.5 | 6.3 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.5 | 2.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.5 | 3.6 | GO:0015232 | heme transporter activity(GO:0015232) |
0.4 | 1.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 5.7 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.4 | 3.0 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.4 | 2.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.4 | 3.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.4 | 18.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.4 | 2.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.4 | 1.2 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.4 | 3.9 | GO:0051425 | PTB domain binding(GO:0051425) |
0.4 | 2.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.4 | 1.1 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.4 | 1.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 4.9 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.4 | 9.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.4 | 4.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.4 | 8.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.4 | 5.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.4 | 4.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.3 | 7.3 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 3.8 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
0.3 | 2.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 1.7 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.3 | 5.5 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.3 | 1.0 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.3 | 7.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.3 | 4.6 | GO:0004875 | complement receptor activity(GO:0004875) |
0.3 | 15.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.3 | 2.0 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.3 | 5.8 | GO:0019864 | IgG binding(GO:0019864) |
0.3 | 1.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 15.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 9.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 30.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 10.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 0.9 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.3 | 9.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 3.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.3 | 1.7 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 1.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 3.7 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.3 | 5.3 | GO:0015485 | cholesterol binding(GO:0015485) |
0.3 | 3.8 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 2.1 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.3 | 6.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 1.0 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.3 | 4.0 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.3 | 14.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 2.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 1.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 3.4 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.2 | 4.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 2.6 | GO:0015266 | protein channel activity(GO:0015266) |
0.2 | 2.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 3.8 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.2 | 3.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 9.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 5.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 18.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 3.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 7.9 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.2 | 2.2 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 4.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 3.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 2.6 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.2 | 1.5 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.2 | 3.8 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 3.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.2 | 4.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 4.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 5.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 1.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 4.6 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 0.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 3.3 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.2 | 25.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 5.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.2 | 3.9 | GO:0004601 | peroxidase activity(GO:0004601) |
0.2 | 1.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 1.0 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.2 | 1.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 2.3 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 3.9 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.2 | 6.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 1.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 0.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 24.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 1.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 0.8 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 7.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 3.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 1.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 2.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 3.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 1.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 3.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 3.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 1.2 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 1.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 1.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 4.7 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.1 | 2.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 1.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 3.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 22.2 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.8 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 4.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.3 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.1 | 2.0 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 2.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 1.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 1.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.6 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 2.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 2.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 1.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.3 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.1 | 9.7 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 7.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 14.6 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.1 | 2.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 2.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 1.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 4.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 2.5 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 18.2 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 12.2 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 0.4 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 1.2 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.6 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.1 | 1.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.7 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.1 | 1.7 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 1.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 2.1 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 4.1 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 2.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 1.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 2.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 27.9 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 2.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 1.6 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 3.4 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 3.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.8 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.4 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 1.7 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.7 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.6 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 34.1 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.5 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 1.0 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 1.9 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.9 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.9 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.3 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 1.1 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.3 | GO:0015144 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 112.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.9 | 15.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.8 | 19.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.7 | 102.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.7 | 13.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.6 | 40.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.5 | 26.1 | PID ATM PATHWAY | ATM pathway |
0.5 | 16.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.5 | 3.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 9.6 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.4 | 9.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 3.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.4 | 15.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.4 | 2.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 16.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 17.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 7.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.4 | 91.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 20.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 16.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 75.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 6.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 7.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 2.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 12.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 18.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 12.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.3 | 10.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 11.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 7.9 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 3.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 7.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 7.0 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 5.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 5.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 11.6 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.2 | 4.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 7.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 10.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 7.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 1.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 5.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 3.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 2.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 2.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 13.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 1.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 3.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 3.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 1.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 109.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.7 | 45.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.6 | 21.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
1.4 | 34.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.2 | 16.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
1.1 | 14.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.0 | 19.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.0 | 12.3 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.9 | 8.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.8 | 3.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.8 | 119.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.8 | 14.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.8 | 45.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.7 | 12.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.7 | 12.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.7 | 37.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.7 | 8.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.7 | 16.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.7 | 11.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.6 | 8.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.6 | 4.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 12.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.5 | 14.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.5 | 1.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.5 | 5.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.5 | 19.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.5 | 13.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.5 | 15.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.5 | 6.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.4 | 6.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 6.7 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.4 | 21.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 16.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.4 | 3.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.4 | 5.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 11.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 10.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 15.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.3 | 7.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 18.0 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.3 | 3.2 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 2.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.3 | 1.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 2.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 3.9 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 4.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 3.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 6.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 4.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 7.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 1.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 0.2 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.2 | 4.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 6.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 4.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 1.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 15.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 2.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 31.7 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.2 | 3.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 3.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 3.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 2.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 9.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 1.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 2.8 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.2 | 20.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 5.8 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.1 | 3.9 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 2.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 5.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 3.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 1.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 3.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 2.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 4.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 45.4 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 2.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 4.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 4.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 1.6 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 1.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 5.6 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 1.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 1.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 2.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 3.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 3.5 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 1.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.8 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 1.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 4.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 2.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 1.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 5.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 2.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |